-
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 2021 19:30 GMT
… -19 Vaccine In UK
Wednesday
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) … (before the market open)
IPO Calendar
IPO Pricing
Hamburg, Germany-based … a 22-million ADS initial public offering at a price of … symbol "NVCT."
IPO Quiet Period Expiry
Theseus …
-
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul 2021 12:56 GMT
… LH) (before the market open)
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) (before … Systems (after the close)
IPOs
Nuvalent, Inc., (NASDAQ: NUVL … in cancer, priced its initial public offering of 9.75 million … diseases, priced its upsized IPO of 12.13 million …
-
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
25 Jul 2021 13:56 GMT
… : WST) (before the market open)
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) (before …
IPOs
IPO Pricing
Philadelphia, Pennsylvania-based Context Therapeutics, Inc. is planning an initial public offering … the ticker symbol OCEA.
IPO Quiet Period Expiry
CVRx, …
-
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
12 Feb 2021 15:46 GMT
… ADAG) (went public Tuesday)
Agios Pharmaceuticals Inc (NASDAQ: AGIO)
AnaptysBio … FDA Decision, Earnings, IPOs and Conference Presentations In … , priced its downsized initial public offering of 2.66 million … Decibel Therapeutics priced its IPO of 7.062 million …
-
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
10 Feb 2021 12:44 GMT
… Biopharma Inc (NASDAQ: NMTR)
Agios Pharmaceuticals Inc (NASDAQ: AGIO)
Amneal … (after the market close)
IPOs
French clinical-stage biotech Biophytis … with aging, priced its initial public offering of 1.2 million … system disorders, priced its IPO of $2.25 million …
-
Newman Ferrara LLP Announces Corporate Governance Investigation of Agios Pharmaceuticals Inc. - AGIO
12 Jul 2017 18:58 GMT
… on behalf of shareholders of Agios Pharmaceuticals Inc.
(“Agios” or the “Company … lackluster performance since its 2013
initial public offering, it is clear that the …
-
C4 Therapeutics Proposes $150 Million IPO Terms
29 Sep 2020 11:29 GMT
… and was previously CFO at Agios Pharmaceuticals. Below is a brief … liabilities. (Unaudited, interim) IPO Details C4 intends to raise … company’s enterprise value at IPO would approximate $743 million, … U.S. IPOs with IPO Edge research.
Members of IPO Edge get …
-
Royalty Pharma Pulls the Off Largest IPO of 2020
17 Jun 2020 05:41 GMT
… source: Getty Images.
The largest initial public offering of 2020 so far is … :BMY) owes its collaboration partner, Agios Pharmaceuticals (NASDAQ:AGIO).
-
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
12 Jun 2020 11:49 GMT
… European Hematology Association Congress Presentations
Agios Pharmaceuticals Inc (NASDAQ: AGIO) reported … uncontrolled Type 2 diabetes patients
IPO
Vaxcyte, Inc., a company … diseases, priced its upsized initial public offering, or IPO, of 15.625 million …
-
Repare Therapeutics Begins U.S. IPO Effort
10 Jun 2020 19:43 GMT
… (LOXO) Blueprint Medicines (BPMC) Agios Pharmaceuticals (AGIO) SpringWorks Therapeutics (SWTX … . (Unaudited, interim) IPO Details Repare intends to … Listed bookrunners of the IPO are Morgan Stanley, … S. IPOs with IPO Edge research.
Members of IPO Edge …